1 / 64

Egypt Medical and Diagnostic Laboratory Service Market

This report presents a strategic analysis of the Egypt Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Egypt Medical and Diagnostic Laboratory Service Market, and offers unmatched value, accuracy, and expert insights.

Insights10
Download Presentation

Egypt Medical and Diagnostic Laboratory Service Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sample Report Egypt Medical and Diagnostic Laboratory Service Market Analysis July 2024

  2. This report presents a strategic analysis of the Egypt Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Egypt Medical and Diagnostic Laboratory Service Market, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Currency Conversion 1 Egyptian Pound = 0.021 USD Research Approach Secondary Research (90%), Primary Research (10%) 3 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 06-14 1. Market Overview 1.1 Medical and Diagnostic Laboratory Service Market Overview 1.2 Medical and Diagnostic Laboratory Service Market Overview: Global 1.3 Economic Overview: Egypt 1.4 Medical and Diagnostic Laboratory Service Market Overview: Egypt 1.5 Healthcare Overview: Egypt 1.6 Budget of Egypt Government for Public Insurance 1.7 Top Developments in Egypt 15-17 2. Effectiveness of Medical and Diagnostic Laboratory Services 2.1 Types of Medical Laboratory Testing 2.2 Benefits and Challenges of Medical and Diagnostic Laboratory Services 18-23 3. Market Size and Forecasting 2.1.3 Egypt Medical and Diagnostic Laboratory Service Market Size and Forecasts 4 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 3.2 Snapshot of Medical and Diagnostic Laboratory Service Market Segmentation 3.2.1 Market Segmentation: By Service Provider 3.2.2 Market Segmentation: By Test Type 3.2.3 Market Segmentation: By Application 24-29 4. Market Dynamics 4.1 Market Growth Drivers 4.2 Market Growth Restraints 30-37 5. Competitive Landscape 5.1 Key Players in Medical and Laboratory Diagnostic Service Market 38-43 6. Regulatory and Reimbursement Landscape in Egypt 6.1 Regulatory Landscape in Egypt 6.2 Reimbursement Scenario in Egypt 6.3 Reimbursement Process 5 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  6. Egypt Medical and Diagnostic Laboratory Service Market Analysis 1. Market Overview

  7. 1.1 Medical and Diagnostic Laboratory Service Overview Medical and Diagnostic Laboratory Services, also known as clinical or pathology lab services, involves the analysis of materials derived from the human body for the diagnosis, prevention or treatment of an illness or diseased condition ▪ Common methods employed for medical and diagnostic services include biological, microbiological, serological, chemical, immuno-hematological, hematological, biophysical, cytological, pathological analysis of the biological sample ▪ Some of the common example of diagnostic services include : X-rays, ultrasounds, MRI, CT Scan, PET Scan ▪ Blood draws, biopsies and lab work, including genetic tests ▪ Strep tests, flu tests, and other types of illness-related tests ▪ Psychological and neuropsychological testing ▪ Fetal stress tests and amniocentesis ▪

  8. 1.2 Medical and Diagnostic Laboratory Service Market Overview: Global (1/2) 74% Deaths globally due to NCDs, equivalent to 41 Mn people annually Global Healthcare Expenditure Per Capita ($Mn) (2012-2021) 1.27 1.18 $1.27 Mn Healthcare expenditure globally in 2021 1.10 1.09 1.04 1.03 1.00 1.00 0.98 0.98 18% Of the total global revenue in the medical technology industry from in vitro diagnostics 1.4 Bn Individuals aged 60 and older estimated in 2030 and 2.1 Bn in 2050 by WHO 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Sources: 8 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  9. 1.2 Medical and Diagnostic Laboratory Service Market Overview: Global (2/2) Egypt Market ~$xx Bn Market Illustrative Illustrative 9 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  10. 1.3 Economic Overview: Egypt Population of Egypt, (Mn) (2014-2023) GDP of Egypt, ($) (2014-2023) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Population Split (2023) Egypt is not an aging country, as it’s median age is 24.2 years which is lower than global median age ▪ By Gender By Age Group Country's population’s global share is 1.4% and it is increasing at a rate of 1.56% Life expectancy of female is 73.2 years and for male it is 68.5 years Currently 41.3% of population is urban in Egypt Top 3 largest cities in Egypt is Cairo, Alexandria, Giza ▪ 5% 0-14 33% ▪ 15-64 Female Male ▪ 65+ ▪ 62% Illustrative Illustrative Sources: 10 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  11. 1.4 Medical and Diagnostic Laboratory Service Market Overview: Egypt Healthcare Expenditure Egypt Per Capita ($) (2011-2020) 82% Of all deaths in Egypt due to Non-Communicable Diseases (NCDs) $179.68 Health expenditure per capita in 2021 in Egypt 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 5% Of the total population in Egypt was aged 65 years and above in 2023 Egypt is not an aging country, as it’s median age is 24.2 years which is lower than global median age ▪ Country's population’s global share is 1.4% and it is increasing at a rate of 1.56% Life expectancy of female is 73.2 years and for male it is 68.5 years Currently 41.3% of population is urban in Egypt Top 3 largest cities in Egypt is Cairo, Alexandria, Giza ▪ ▪ 13 Mn Egyptians receive screening for chronic diseases and kidney disease ▪ ▪ Illustrative Illustrative Sources: 11 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  12. 1.5 Healthcare Overview: Egypt Public Healthcare Private Healthcare Universal Coverage: Via a network of public clinics, hospitals, and healthcare facilities, the government offers fundamental universal health coverage Complimentary: Although the public healthcare sector ensure affordability and accessibility for every individual, the private healthcare sector offers its own advantages ▪ ▪ Funding: Public sector relies heavily on the government funding which can be limited. The consequences of this often leads to issues such as over crowding, understaffing, and limited access to diagnosis and treatment Funding: Private healthcare facilities rely on user fees and insurance payments, which can be varied and unspecific ▪ ▪ Private healthcare facilities offer a more comfortable patient experience, advanced technologies, and access to a wider range of specialist services ▪ Benefits: Public sector provides essential healthcare services to a large portion of the population, especially those with lower incomes, leading to affordability and accessibility for everyone ▪ Cost: High cost associate with private healthcare services can be a significant barrier for many Egyptians ▪ Challenges: Limitations in funding can lead to challenges in service quality, access to specialists, and availability of advanced treatments ▪ Illustrative Illustrative 12 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  13. 1.6 Budget of Egypt Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 13 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  14. 1.7 Top Developments in Egypt Latest Deals in Egypt Company Name Type Year Key Pointers Meden Healthcare, a part of the Saham Sante Group, engaged in the sale of its indirect stake in Hassab Labs Egypt. Hassab Labs is a fast- growing diagnostics laboratory chain in Egypt Acquisition was made by Al Tayeer International Hospital ▪ Acquisition 2020 ▪ Abu Dhabi Holding Company (ADQ) which was rebranded to Abu Dhabi Developmental Holding Company is one of the region's largest holding companies. Amoun Pharmaceutical Company S.A.E. is a leading Egyptian manufacturer, distributor, and exporter of branded pharmaceutical and animal health products Amoun's well-known brand, extensive distribution network, and experience producing and distributing pharmaceuticals complemented ADQ's goals to establish a strong pharmaceutical value chain in UAE Acquisition by ADQ provided Amoun with access to new resources and markets, facilitating future expansion ▪ Acquisition March, 2021 ▪ ▪ Illustrative Illustrative 14 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  15. Egypt Medical and Diagnostic Laboratory Service Market Analysis 2. Overview of Medical & Diagnostic Laboratory Services

  16. 2.1 Types of Medical Laboratory Testing Type of Laboratory Description Key Features Private Laboratories Conduct laboratory testing outside the public hospital system Often referred by general practitioners and private doctors Large diagnostic labs with specialized departments • • Hospital Laboratories Operate within hospitals, serving various departments and needs Open 24/7 to meet emergency and inpatient testing requirements Divided into sections (microbiology, hematology, etc.) ▪ ▪ Point-of-Care Testing (POCT) Perform tests at the patient's location, thus providing immediate results Convenient and fast tests conducted at the bedside or clinics Primarily used for simple tests (biochemistry, glucose, etc.) ▪ ▪ Home Testing Enable individuals to perform self-tests in their homes which can be sent for evaluation at specific labs Self-tests for pregnancy, blood glucose, etc. Convenient and accessible for monitoring and quick results ▪ ▪ Illustrative Illustrative 16 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  17. 2.2 Benefits and Challenges of Medical and Diagnostic Laboratory Services Benefits Challenges Early Detection: If detected early enough, many diseases are successfully treatable. Before symptoms even appear, lab testing can spot anomalies or possible problems, enabling early intervention and possibly better results. Financial Pressures: Diagnostic labs face pressure to offer high- quality services at an affordable price. This may result in lower expenditures for new machinery and technology, which would affect productivity and the variety of tests available • • Accurate Diagnosis: Objective data from laboratory testing aid doctors in making precise diagnoses. This can ensure that the best possible treatment plan is started and help prevent misdiagnosis. Test Standardization: For reliable comparisons, test standards throughout laboratories must be maintained. However variations can result in discrepancies • • Monitoring Treatment Effectiveness: Lab tests can be used to monitor the effectiveness of medications or other treatments. They can help determine if the treatment is working, identify potential side effects, and adjust the treatment plan as needed. Turnaround Time: For patients and healthcare professionals, the amount of time it takes to process a test and provide the findings is critical. Labs work hard to streamline processes and reduce turnaround times, but with so few resources and so many tests, this can be difficult • • Preventative Healthcare: Certain tests can assess an individual's risk for developing specific diseases which allow for preventive measures and early intervention to be implemented, potentially preventing the disease altogether. • Data management: A lot of data is produced in today's laboratories. For patient care, effective and secure data management is essential, but it requires robust data management systems and expertise • Illustrative Illustrative 17 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  18. Egypt Medical and Diagnostic Laboratory Service Market Analysis 3. Market Size and Forecasting

  19. 3.1 Egypt Medical and Diagnostic Laboratory Service Market Size and Forecasts Egypt Medical and Diagnostic Laboratory Service Market Forecast, 2023-2030 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Egypt Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Egypt Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 19 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  20. 3.2 Snapshot of Medical and Diagnostic Laboratory Service Market Segmentation Service Provider Test Type Application Hospitals and Clinics Hematology Disease Diagnosis Independent Service Providers Clinical Biochemistry Disease Monitoring Immunology Screening Tests Histology and Cytology Clinical Trials Others In this section you will get an understanding of the segmentations which will cover the Egypt Medical and Diagnostic Laboratory Service Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 20 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  21. 3.2.1 Market Segmentation: By Service Provider Egypt Medical and Diagnostic Laboratory Service Market Share, By Service Provider (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Independent Service Providers ▪ Hospitals and Clinics Illustrative Illustrative 21 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  22. 3.2.2 Market Segmentation: By Test Type Egypt Medical and Diagnostic Laboratory Service Market Share, By Test Type (2023) Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Hematology Histology and Cytology ▪ ▪ Immunology Clinical Biochemistry Illustrative Illustrative 22 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  23. 3.2.3 Market Segmentation: By Application Egypt Medical and Diagnostic Laboratory Service Market Share, By Application (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Clinical Trials ▪ Disease Diagnosis ▪ Screening Tests ▪ Disease Monitoring Illustrative Illustrative 23 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  24. Egypt Medical and Diagnostic Laboratory Service Market Analysis 4. Market Dynamics

  25. 4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 4.1.2 Rapid advancements in laboratory technology lead to efficient diagnosis 4.1.3 In Egypt, NCDs are the leading cause of death and cause 82% of all deaths and 67% of premature deaths Increasing trend of personalized medicine and early diagnosis for better treatment outcomes 4.2.1 High costs associated with advanced diagnostic equipment and technologies 4.2.2 Shortage of skilled technicians and scientists can prevent the growth of the market Illustrative Illustrative 25 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  26. 4.1 Market Growth Drivers 4.1.1 Rising morbidity and mortality leading to healthcare burden in Egypt, where 41% of all deaths are caused due to chronic diseases Prevalence of Various Chronic Diseases in Egypt Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 26 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  27. 4.1 Market Growth Drivers 4.1.2 Continuous development of new technologies such as molecular diagnostics, automation, and AI is revolutionizing the laboratory field Rising Healthcare Expenditure in Technology Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 27 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  28. 4.1 Market Growth Drivers 4.1.3 Personalized medicine fuels the medical and diagnostic lab service market be demanding tailored diagnostic tests to guide the treatment decisions Personalized Medicine In Various Healthcare Segments Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 28 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  29. 4.2 Market Growth Restraints 4.2.1 High cost of the medical and diagnostic laboratory services faces resistance from the patients which ultimately hinder the growth 4.2.2 Inadequate supply of healthcare professionals to deliver the services of the lab prevents the growth of the market to its full potential Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 29 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  30. Egypt Medical and Diagnostic Laboratory Service Market Analysis 5. Competitive Landscape

  31. 5.1 Key Players in Egypt Medical and Diagnostic Laboratory Service Market Here is the list of top 10 companies which will cover in the final report ▪ 1 6 Each company will have slides for ▪ Alfa Laboratories El Nour Lab Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o o o o 2 7 Alborg Labs Dr. Abdel Fattah Lab o o o 3 8 Dar Al Fouad Hospital El Menshawy Lab o ▪ 4 9 Hassab Labs Horus Lab ▪ 10 5 Royal Lab El Maghfera Lab 31 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  32. 5.1.1 Alfa Laboratories Offerings ▪ Alfa Laboratories, member of the Alfa Medical Group, is one of the leading pathology laboratories in Egypt ▪ It operates over 200+ branches, supporting patients all over Egypt with its widespread network and home visits, Alfa labs provides a variety of lab tests at patients’ convenience ▪ Alfa Laboratories aims to promote health through the provision of clinical laboratory testing services, including highly advanced methods for prevention, early diagnosis, and comprehensive management of diseases at a reasonable cost. Founded In: 1998 ➢ Laboratory Tests HQ: Giza, Egypt ➢ Diagnostic Profile Creation Type: Private Revenue: $3.8 Mn ➢ Pre-Employment Testing Website: www.alfalab.com ➢ Screening for Drivers Diagnostic Profiles Small, Medium, Large, and Full Checkup Rapid Weight loss in Males and Females Liver Function Tests Vitamins and Minerals Profile Above 40 Screening Profile Metabolic Panel Cardiac Profile House Workers Profile Children Check Up Profile Premarital Screening Cardiovascular Risk Profile Osteoporosis Thrombophilia Screening Profile Neonatal Screening Kidney Function Tests Screening for Chronic Headache Screening for Recurrent Miscarriage Follow Up for Hypertensive Patients Covid-19 Screening Profile Pregnancy A Sample Report on Egypt Medical and Diagnostic Laboratory Service 32 Market Analysis I Confidential

  33. 5.1.1 Alfa Laboratories (Continued) Latest Deals in Alfa Laboratories Company Name Type Year Key Pointers UK’s development finance institute CDC Group along with healthcare investor Africa Platform Capital announced a $100 Mn Minority Equity Investment in Egypt based diagnostics and medical care Alfa Medical Group Company It will allow AMG to improve its medical health services, increase public access to medical care, upskill healthcare workers, and expand its hospital footprint. It will also allow the company to expand its laboratory services across Egypt, especially of Alfa Scan Radiology Centre ▪ Investment 2021 ▪ Alfa Medical Group (AMG) and Novartis collaborated to improve cardiovascular health in Egypt. The collaboration was part of a broader initiative called the "Unblocked Movement." The agreement aimed to develop targeted tools and resources to enhance the patient journey for those suffering from Atherosclerotic Cardiovascular Disease (ASCVD). The goals of the agreement were to raise awareness about ASCVD and its risk factors and educate patients about effective disease management ▪ ▪ Collaboration 2023 ▪ Illustrative Illustrative A Sample Report on Egypt Medical and Diagnostic Laboratory Service 33 Market Analysis I Confidential

  34. 5.1.1 Alfa Laboratories (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative A Sample Report on Egypt Medical and Diagnostic Laboratory Service 34 Market Analysis I Confidential

  35. 5.1.2 Company 2 Offerings Founded In: HQ: Type: Revenue: Website: Recent Activity / Press Coverage Illustrative Illustrative A Sample Report on Egypt Medical and Diagnostic Laboratory Service 35 Market Analysis I Confidential

  36. 5.1.2 Company 2 (Continued) Latest Deals in CompanyName Company Name Type Year Key Pointers Illustrative Illustrative A Sample Report on Egypt Medical and Diagnostic Laboratory Service 36 Market Analysis I Confidential

  37. 5.1.2 Company 2 (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative A Sample Report on Egypt Medical and Diagnostic Laboratory Service 37 Market Analysis I Confidential

  38. Egypt Medical and Diagnostic Laboratory Service Market Analysis 6. Regulatory and Reimbursement Landscape

  39. 6.1 Regulatory Landscape in Egypt Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Egypt Pharmaceutical regulatory body in Egypt is the Egyptian Drug Authority (EDA) operating and working under supervision of the Ministry of Health (MoH) in Egypt. Many organizations within the EDA work collaboratively to ensure all medicinal products are safely regulated for efficient public access, while maintaining compliance. EDA CAPA NODCR NORCB Central Administration for Pharmaceutical Affairs (CAPA): Handles drug registration and pricing, along with inspections of pharmacies and manufacturing facilities National Organization for Drug Control and Research (NODCR): Responsible for quality control of pharmaceutical products, medicines, medical plants, cosmetics, raw materials, and products of natural origin National Organization for Research & Control of Biologicals (NORCB): Deals with marketing authorizations and licensing activities for biological products ▪ ▪ ▪ Illustrative Illustrative 39 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  40. 6.2 Reimbursement Scenario in Egypt Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs Drug Approval Process: ▪ Drug approval starts with a pharmaceutical company submitting an application for seeking market authorization of the drug product. The dossier required to be submitted generally includes comprehensive information about the drug including the Chemistry, Manufacturing, and Control (CMC), non-clinical study data, clinical study data, quality control data, packaging and labeling information for the finished drug product Applicant submits the completed dossier and relevant fees to the CAPA within the EDA CAPA performs an initial administrative review to ensure the application is complete and follows the guidelines If the application passes the initial review, the EDA assigns a team of experts for rigorous evaluation and review on safety, efficacy, and quality of the drug product. The various committees involved in the review generally include technical committee, bioequivalence committee, stability committee, and naming committee Next, the application is forwarded to the NODCAR for additional quality control testing of the drug product. Along with a thorough review and evaluation of the submitted documents, the EDA conducts an inspection of the manufacturing facilities for the drug product to ensure compliance with Good Manufacturing Practices (GMP) After the successful completion of all stages and upon recommendation and approval from various committees involved in the drug approval process, the final approval for the marketing authorization is granted from the Ministry of Health (MoH) Role of the regulatory authority of Egypt does not end here, but also has a crucial role to play in the post-marketing surveillance of the drug product to in case of any adverse drug reporting related to the drug product ▪ ▪ ▪ ▪ ▪ ▪ ▪ Illustrative Illustrative 40 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  41. 6.2 Reimbursement Scenario in Egypt (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in Egypt healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 41 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  42. 6.3 Reimbursement Process The reimbursement process in Egypt healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 42 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  43. 6.3 Reimbursement Process (Continued) The reimbursement process in Egypt healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 43 A Sample Report on Egypt Medical and Diagnostic Laboratory Service Market Analysis I Confidential

  44. A division of

  45. Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com www.insights10.com

  46. Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com www.insights10.com

  47. Global Coverage Europe • UK • Germany • France • Italy • Spain • Russia • Netherlands • Sweden • Romania • Switzerland • Poland • Austria • Ireland • Norway • Denmark • Belgium • Portugal • Ukraine • Bulgaria • Finland APAC • India • China • South Korea • Japan • Australia • Indonesia • Hong Kong • New Zealand • Philippines • Singapore • Malaysia • Thailand • Vietnam North America • US • Canada Africa • Egypt • Kenya • South Africa • Algeria • Nigeria • Libya • Tanzania • Morocco Middle East • UAE • Saudi Arabia • Turkey • Lebanon • Kuwait • Qatar Latin America • Brazil • Argentina • Mexico • Ecuador • Venezuela • Senegal Click on the country to see the reports available

  48. What do our reports cover? Market Overview Competitive Landscape 1 6 Growth Drivers & Growth Restraints 2 7 Policy & Regulatory Landscape Epidemiology & Disease type 3 8 Reimbursement Scenario Market Size & Forecast Recent Developments 4 9 Market Segmentation Factors Driving Future Growth 5 10

  49. Our Research Process 01 02 03 04 05 06 Define precise research questions Gather data through secondary research Validate data through primary research interviews Forecast market size and segment analysis Extract key insights from the research findings Compile & present a comprehensive analytical report

  50. Data Triangulation & Data Validation Top Down Approach Find final Examine the total healthcare expenditure in the targeted disease or service domain. market size Assess the proportion of spending allocated to the specific product or treatment category. Predict future market growth or decline based on key market trends & dynamics Predict future market growth or decline based on key market trends & dynamics Analyze product or treatment pricing and reimbursement strategies Find final market size Evaluate consumer or patient demographics and numbers Bottom Up Approach

More Related